House Status:
Senate Status:
Senate Status:
HB 2218 Committee Minutes and Testimony
Amending the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin and adding crystalline polymorph psilocybin to schedule IV of the uniformed controlled substance act.
House Committee on Health and Human Services
| Hearing Date | Minutes | Testimony | Presenter | Organization | Topic |
|---|---|---|---|---|---|
| Tue, Feb 11, 2025 | View | Download | Tess Bettler | Compass Pathways | A01 HB2218 |
| Tue, Feb 11, 2025 | View | Download | James Davis | Private Citizen | A02 HB2218 |
| Tue, Feb 11, 2025 | View | Download | Alexandra Blasi | Kansas Board of Pharmacy | A03 HB2218 |
